SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-19-016844
Filing Date
2019-11-12
Accepted
2019-11-12 09:29:08
Documents
36

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 3130025
2 ex10-9.htm EX-10.9 535620
3 ex23-1.htm EX-23.1 5199
4 ex23-1.jpg GRAPHIC 4555
5 ex23-2.jpg GRAPHIC 17229
6 logo_001.jpg GRAPHIC 7222
7 drs_004.jpg GRAPHIC 41195
8 drs_005.jpg GRAPHIC 41040
9 drs_018.jpg GRAPHIC 21867
10 drs_012.jpg GRAPHIC 21867
11 drs_013.jpg GRAPHIC 68810
12 drs_014.jpg GRAPHIC 69315
13 drs_002.jpg GRAPHIC 19365
14 chart_001.jpg GRAPHIC 22639
15 chart_002.jpg GRAPHIC 16401
16 chart_003.jpg GRAPHIC 10887
17 drs_019.jpg GRAPHIC 41560
18 image_012.jpg GRAPHIC 30289
19 image_019.jpg GRAPHIC 50123
20 image_021.jpg GRAPHIC 90062
21 image_022.jpg GRAPHIC 60734
22 image_027.jpg GRAPHIC 40094
23 image_028.jpg GRAPHIC 71239
24 image_056.jpg GRAPHIC 63223
25 logo_002.jpg GRAPHIC 14035
26 finance_002.jpg GRAPHIC 35223
27 finance_001.jpg GRAPHIC 14035
28 attach2_001.jpg GRAPHIC 5680
29 attach2_002.jpg GRAPHIC 2703
30 attach2_003.jpg GRAPHIC 8777
31 attachment1_001.jpg GRAPHIC 7479
32 ex10-10_001.jpg GRAPHIC 12299
33 ex10-10_1.jpg GRAPHIC 16779
34 ex10-10_2.jpg GRAPHIC 17317
35 attachment1_002.jpg GRAPHIC 31814
36 report_001.jpg GRAPHIC 1784
  Complete submission text file 0001493152-19-016844.txt   5022027
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: F-1/A | Act: 33 | File No.: 333-234292 | Film No.: 191206608
SIC: 2834 Pharmaceutical Preparations